Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To compare the prevalence of hypertension and pre-existing use of renin-angiotensin-aldosterone system blockers in patients with coronavirus disease (COVID-19) and non-COVID-19 viral pneumonias.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Turk Kardiyol Dern Ars

Title: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

Publisher: Turkish Society of Cardiology

ISSN (Electronic): 1308-4488

ISSN (Print): 1016-5169

Publication date (Electronic): Jun 2021

Volume: 49

Issue: 4

Affiliations

[1 ] Department of Cardiology, Acıbadem Mehmet Ali Aydınlar University School of Medicine, İstanbul, Turkey.

[2 ] Department of Chest Diseases and Tuberculosis, Faculty of Medicine, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.

[3 ] Department of Cardiology, Acibadem Altunizade Hospital, Acibadem Healthcare Group, Istanbul, Turkey.

[4 ] Department of Cardiology, Acibadem Maslak Hospital, Acibadem Healthcare Group, Istanbul, Turkey.

[5 ] Muhimbili University of Health and Allied Sciences, Department of Biochemistry, MUHAS Genetics Laboratory, Dar es Salaam, Tanzania.

[6 ] Department of Family Health, Child Health Institute, Istanbul University, Istanbul, Turkey.

[7 ] Department of Infectious Diseases, Acibadem Kadikoy - Kozyatagi Hospitals, Acibadem Healthcare Group, Istanbul, Turkey.

[8 ] Department of First and Emergency Aid, Vocational School of Health Services, Acibadem Mehmet Ali Aydinlar University, Istanbul, Turkey.

Article

DOI: 10.5543/tkda.2021.87750

PubMed ID: 34106062

SO-VID: 37d223b5-a710-4332-a3f7-5df40868eb00

History

Data availability:

Comparison of hypertension prevalence and the use of renin-angiotensin-aldosterone system blockers in hospitalized patients with COVID-19 and non-COVID-19 viral pneumonia.

Read this article at

Abstract

Related collections

Novel Coronavirus Disease COVID-19

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 186

Cited by 1